Actively Recruiting
Expanding Access to Safe Water in Nigeria
Led by University of Michigan · Updated on 2025-11-24
700
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
U
University of Michigan
Lead Sponsor
P
Princeton University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Access to safe water remains a pressing public health challenge in Nigeria, where 67% of the population lacks safely managed drinking water and waterborne diseases cause an estimated 70,000 child deaths annually. Building on evidence that point-of-use chlorination is highly cost-effective in reducing diarrheal disease, this study evaluates a scalable, community-based chlorine distribution model through a cluster-randomized controlled trial (RCT) in Kano State. Thirty communities across four Local Government Areas will be randomly assigned to one of three groups: (i) 20 treatment communities receiving community demonstrations and local chlorine redemption points, (ii) 10 control communities where no intervention will be conducted. After 3 months, 5 control communities will receive an individual-level sensitization and a voucher program and 5 will remain pure control communities. The RCT aims to estimate the causal impact of the community-based intervention on household chlorination rates, water quality (E. coli contamination), and knowledge of safe water practices over six months. By rigorously testing a community-led water treatment model, this study contributes new evidence on sustainable and cost-effective approaches to expand safe water access in low-resource settings. The results will inform national and regional strategies for scaling point-of-use chlorination across sub-Saharan Africa.
CONDITIONS
Official Title
Expanding Access to Safe Water in Nigeria
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant mothers
- Women with children under 5 years old
You will not qualify if you...
- Men
- Women without children under 5 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kura, Dawakin Kudu, Kiru, and Rano LGAs
Kano, Nigeria
Actively Recruiting
Research Team
E
Elisa Maria Maffioli, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here